Kythera Biopharmaceuticals, Inc. Garners $10,000,000 Series C Funding Round

  • Feed Type
  • Date
  • Company Name
    Kythera Biopharmaceuticals, Inc.
  • Mailing Address
    27200 West Agoura Road Calabasas, CA 91301
  • Company Description
    Kythera is focused on science and innovation in aesthetic and restorative dermatology. These markets are expanding rapidly driven by an aging population, increasing discretionary income, and an evolution of patient preference toward restorative and preventative care. The company uses the tools of biotechnology to develop prescription therapeutics for these emerging markets.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    This additional investment commitment, combined with our existing cash reserves, increases KYTHERA’s financial strength and enables us to advance the clinical development of KYTHERA’s two clinical stage compounds and pre-clinical pipeline. Additionally, this early exercise of the option is a clear acknowledgement of the promising data recently announced from the Phase 2 trials on our lead product candidate, ATX-101.
  • M&A Terms
  • Venture Investor
    Versant Ventures
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Prospect Venture Partners
  • Venture Investor
    BBT Fund
  • Venture Investor
    Apothecary Capital
  • Venture Investor
    Jafco Ventures America Inc
  • Venture Investor
    Altitude Life Science Ventures

Trending on Xconomy